Most linked-to pages

Jump to navigation Jump to search

Showing below up to 50 results in range #12,301 to #12,350.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Cavarretta IT, et al. Mol. Ther. (2010) cited as Ref 493 in DOI: 10.1038/s41392-020-0110-5 (Q9756)‏‎ (2 links)
  2. Tahotna A, et al, Interdiscip. Toxicol. (2018), cited as Ref 13 in DOI: 10.1016/j.jcv.2020.104372 (Q10460)‏‎ (2 links)
  3. Zinke J, et al. Mol. Cancer (2015) cited as Ref 269 in DOI: 10.1038/s41392-020-0110-5 (Q9532)‏‎ (2 links)
  4. Pemmaraju N, et al. Blood (2016) cited as Ref 558 in DOI: 10.1038/s41392-020-0110-5 (Q9821)‏‎ (2 links)
  5. Tu B, et al. Cancer Lett. (2012) cited as Ref 501 in DOI: 10.1038/s41392-020-0110-5 (Q9764)‏‎ (2 links)
  6. Wan Y, et al, J. Virol. (2020), cited as Ref 21 in DOI: 10.1016/j.jcv.2020.104372 (Q10468)‏‎ (2 links)
  7. May MJ, et al. Semin. Cancer Biol. (1997) cited as Ref 277 in DOI: 10.1038/s41392-020-0110-5 (Q9540)‏‎ (2 links)
  8. Meurette O, et al. Cancer Cell (2018) cited as Ref 566 in DOI: 10.1038/s41392-020-0110-5 (Q9829)‏‎ (2 links)
  9. Luke Logan kickoff for 65 yds Henry Ruggs III return for 22 yds to the Alab 22 (9-30-17)‏‎ (2 links)
  10. Peng D, et al. Cancer Res. (2016) cited as Ref 509 in DOI: 10.1038/s41392-020-0110-5 (Q9772)‏‎ (2 links)
  11. JK Scott kickoff for 65 yds for a touchback (10-14-17c)‏‎ (2 links)
  12. Yudin MH, et al, Obstet. Gynecol. (2005), cited as Ref 29 in DOI: 10.1016/j.jcv.2020.104372 (Q10476)‏‎ (2 links)
  13. Karin M, et al. Cold Spring Harb. Perspect. Biol. (2009) cited as Ref 285 in DOI: 10.1038/s41392-020-0110-5 (Q9548)‏‎ (2 links)
  14. Hayakawa Y, et al. Gastroenterology (2019) cited as Ref 574 in DOI: 10.1038/s41392-020-0110-5 (Q9837)‏‎ (2 links)
  15. Murai T, et al. Front. Immunol. (2015) cited as Ref 517 in DOI: 10.1038/s41392-020-0110-5 (Q9780)‏‎ (2 links)
  16. American College of Obstetricians and Gynecologists, et al, (2020), cited as Ref 37 in DOI: 10.1016/j.jcv.2020.104372 (Q10484)‏‎ (2 links)
  17. Wang D, et al. Gastroenterology (2015) cited as Ref 293 in DOI: 10.1038/s41392-020-0110-5 (Q9556)‏‎ (2 links)
  18. Zhang J, et al, Lancet Infect Dis (2020), cited as Ref 4 in DOI: 10.1016/j.clim.2020.108427 (Q11247)‏‎ (2 links)
  19. Jalen Hurts run for 13 yds to the TexAM 49 for a 1ST down (10-7-17) (Q2691)‏‎ (2 links)
  20. Zhang S, et al. Cancer Biol. Ther. (2014) cited as Ref 582 in DOI: 10.1038/s41392-020-0110-5 (Q9845)‏‎ (2 links)
  21. Chow A, et al. Sci. Rep. (2014) cited as Ref 525 in DOI: 10.1038/s41392-020-0110-5 (Q9788)‏‎ (2 links)
  22. Chen Y, et al, Front. Pediatr. (2020), cited as Ref 45 in DOI: 10.1016/j.jcv.2020.104372 (Q10492)‏‎ (2 links)
  23. Han D, et al. Oncotarget (2015) cited as Ref 301 in DOI: 10.1038/s41392-020-0110-5 (Q9564)‏‎ (2 links)
  24. Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 12 in DOI: 10.1016/j.clim.2020.108427 (Q11255)‏‎ (2 links)
  25. LoConte NK, et al. Invest. N. Drugs (2015) cited as Ref 590 in DOI: 10.1038/s41392-020-0110-5 (Q9853)‏‎ (2 links)
  26. Andrew R, et al. Eur. J. Cancer (2014) cited as Ref 533 in DOI: 10.1038/s41392-020-0110-5 (Q9796)‏‎ (2 links)
  27. Bartick M, et al, (2020), cited as Ref 53 in DOI: 10.1016/j.jcv.2020.104372 (Q10500)‏‎ (2 links)
  28. Quintas-Cardama A, et al. Clin. Cancer Res. (2013) cited as Ref 309 in DOI: 10.1038/s41392-020-0110-5 (Q9572)‏‎ (2 links)
  29. Dong Y, et al, Journal (2020), cited as Ref 20 in DOI: 10.1016/j.clim.2020.108427 (Q11263)‏‎ (2 links)
  30. JK Scott kickoff for 65 yds Clyde Chriss return for 19 yds to the TexAM 19 (10-7-17) (Q2707)‏‎ (2 links)
  31. Thayer SP, et al. Nature (2003) cited as Ref 598 in DOI: 10.1038/s41392-020-0110-5 (Q9861)‏‎ (2 links)
  32. Donnarumma E, et al. Oncotarget (2017) cited as Ref 541 in DOI: 10.1038/s41392-020-0110-5 (Q9804)‏‎ (2 links)
  33. Schleiss MR, et al, Clin. Infect. Dis. (2019), cited as Ref 61 in DOI: 10.1016/j.jcv.2020.104372 (Q10508)‏‎ (2 links)
  34. Roder S, et al. Exp. Hematol. (2001) cited as Ref 317 in DOI: 10.1038/s41392-020-0110-5 (Q9580)‏‎ (2 links)
  35. Rabi FA, et al, Journal (2020), cited as Ref 28 in DOI: 10.1016/j.clim.2020.108427 (Q11271)‏‎ (2 links)
  36. Berlin J, et al. Clin. Cancer Res. (2013) cited as Ref 606 in DOI: 10.1038/s41392-020-0110-5 (Q9869)‏‎ (2 links)
  37. Ghielmini M, et al. Ann. Oncol. (2000) cited as Ref 549 in DOI: 10.1038/s41392-020-0110-5 (Q9812)‏‎ (2 links)
  38. Yu H, et al. Nat. Rev. Cancer (2009) cited as Ref 325 in DOI: 10.1038/s41392-020-0110-5 (Q9588)‏‎ (2 links)
  39. Millet JK, et al, Journal (2014), cited as Ref 36 in DOI: 10.1016/j.clim.2020.108427 (Q11279)‏‎ (2 links)
  40. Cortes JE, et al. Am. J. Hematol. (2018) cited as Ref 614 in DOI: 10.1038/s41392-020-0110-5 (Q9877)‏‎ (2 links)
  41. Frankel AE, et al. Blood (2014) cited as Ref 557 in DOI: 10.1038/s41392-020-0110-5 (Q9820)‏‎ (2 links)
  42. Wu JT, et al, Lancet (2020), cited as Ref 6 in DOI:10.14218/ERHM.2020.00023 (Q10781)‏‎ (2 links)
  43. Zhang X, et al. Cell Death Dis. (2018) cited as Ref 333 in DOI: 10.1038/s41392-020-0110-5 (Q9596)‏‎ (2 links)
  44. Fujimoto I, et al, Journal (2000), cited as Ref 44 in DOI: 10.1016/j.clim.2020.108427 (Q11287)‏‎ (2 links)
  45. End of 2nd Quarter (10-7-17)‏‎ (2 links)
  46. Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5 (Q9885)‏‎ (2 links)
  47. Movement Disorders (disease - MeSH descriptor) (Q11043)‏‎ (2 links)
  48. Buchanan L, et al, New York Times (2020), cited as Ref 14 in DOI:10.14218/ERHM.2020.00023 (Q10789)‏‎ (2 links)
  49. Brown JA, et al. Cell Stem Cell (2017) cited as Ref 341 in DOI: 10.1038/s41392-020-0110-5 (Q9604)‏‎ (2 links)
  50. Xu Z, et al, Journal (2020), cited as Ref 52 in DOI: 10.1016/j.clim.2020.108427 (Q11295)‏‎ (2 links)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:MostLinkedPages"